Literature DB >> 23623574

Serum 25-hydroxyvitamin D deficiency and the 5-year incidence of CKD.

Matthew J Damasiewicz1, Dianna J Magliano, Robin M Daly, Claudia Gagnon, Zhong X Lu, Ken A Sikaris, Peter R Ebeling, Steven J Chadban, Robert C Atkins, Peter G Kerr, Jonathan E Shaw, Kevan R Polkinghorne.   

Abstract

BACKGROUND: Low serum 25-hydroxyvitamin D (25[OH]D) levels have been associated with chronic kidney disease in cross-sectional studies. However, this association has not been studied prospectively in a large general population-based cohort. STUDY
DESIGN: Prospective cohort study. SETTING &amp; PARTICIPANTS: 6,180 adults 25 years or older participating in the baseline and 5-year follow-up phases of the Australian Diabetes, Obesity and Lifestyle (AusDiab) Study. PREDICTOR: Serum 25(OH)D levels <15 ng/mL were considered deficient. OUTCOMES &amp; MEASUREMENTS: Incident chronic kidney disease was defined as being negative at baseline but positive after 5 years for (1) reduced estimated glomerular filtration rate (eGFR; <60 mL/min/1.72 m²) or (2) albuminuria (spot urine albumin-creatinine ratio ≥2.5 mg/mmol [≥22.1 mg/g] for men and ≥3.5 mg/mmol [≥30.9 mg/g] for women).
RESULTS: 623 (10.9%) participants were vitamin D deficient, 161 developed incident reduced eGFR, and 222 developed incident albuminuria. In participants with and without vitamin D deficiency, annual age-standardized incidences were 0.92% (95% CI, 0.56%-1.30%) and 0.59% (95% CI, 0.51%-0.68%), respectively, for eGFR <60 mL/min/1.72 m² and 1.50% (95% CI, 1.06%-1.95%) and 0.66% (95% CI, 0.56%-0.76%), respectively, for albuminuria. In multivariate regression models, vitamin D deficiency was associated significantly with the 5-year incidence of albuminuria (OR, 1.71; 95% CI, 1.12-2.61; P = 0.01), but not reduced eGFR (OR, 0.93; 95% CI, 0.53-1.66; P = 0.8). LIMITATIONS: The observational nature of the study does not account for unmeasured confounders. Only baseline 25(OH)D level was measured and therefore may not accurately reflect lifetime levels. Differences in baseline characteristics of participants who were included compared with those excluded due to missing data or follow-up may limit the applicability of results to the original AusDiab cohort.
CONCLUSIONS: Our prospective cohort study shows that vitamin D deficiency is associated with a higher annual incidence of albuminuria and reduced eGFR and independently predicts the 5-year incidence of albuminuria. These associations warrant further exploration in long-term prospective clinical trials.
Copyright © 2013 National Kidney Foundation, Inc. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23623574     DOI: 10.1053/j.ajkd.2013.03.010

Source DB:  PubMed          Journal:  Am J Kidney Dis        ISSN: 0272-6386            Impact factor:   8.860


  14 in total

1.  Serum 25-hydroxyvitamin D level and kidney function decline in a Swiss general adult population.

Authors:  Idris Guessous; William McClellan; David Kleinbaum; Viola Vaccarino; Henry Hugues; Olivier Boulat; Pedro Marques-Vidal; Fred Paccaud; Jean-Marc Theler; Jean-Michel Gaspoz; Michel Burnier; Gérard Waeber; Peter Vollenweider; Murielle Bochud
Journal:  Clin J Am Soc Nephrol       Date:  2015-04-21       Impact factor: 8.237

2.  Vitamin D Status and Kidney Function Decline in HIV-Infected Men: A Longitudinal Study in the Multicenter AIDS Cohort Study.

Authors:  Adrienne Tin; Long Zhang; Michelle M Estrella; Andy Hoofnagle; Casey M Rebholz; Todd T Brown; Frank J Palella; Mallory D Witt; Lisa P Jacobson; Lawrence A Kingsley; Alison G Abraham
Journal:  AIDS Res Hum Retroviruses       Date:  2017-09-05       Impact factor: 2.205

3.  Deficient serum 25-hydroxyvitamin D is associated with an atherogenic lipid profile: The Very Large Database of Lipids (VLDL-3) study.

Authors:  Joshua R Lupton; Kamil F Faridi; Seth S Martin; Sristi Sharma; Krishnaji Kulkarni; Steven R Jones; Erin D Michos
Journal:  J Clin Lipidol       Date:  2015-09-25       Impact factor: 4.766

4.  Vitamin D and Albuminuria in Youth with and without Type 1 Diabetes.

Authors:  Debika Nandi-Munshi; Maryam Afkarian; Kathryn B Whitlock; Jamie L Crandell; Ronny A Bell; Ralph D'Agostino; Sharon Saydah; Amy K Mottl; Dana Dabelea; Mary Helen Black; Elizabeth J Mayer-Davis; Catherine Pihoker
Journal:  Horm Res Paediatr       Date:  2017-05-29       Impact factor: 2.852

5.  Plasma Vitamin D Level and Change in Albuminuria and eGFR According to Sodium Intake.

Authors:  Charlotte A Keyzer; Hiddo J Lambers-Heerspink; Michel M Joosten; Petronella E Deetman; Ron T Gansevoort; Gerjan Navis; Ido P Kema; Dick de Zeeuw; Stephan J L Bakker; Martin H de Borst
Journal:  Clin J Am Soc Nephrol       Date:  2015-10-08       Impact factor: 8.237

6.  Negative effect of vitamin D on kidney function: a Mendelian randomization study.

Authors:  Alexander Teumer; Giovanni Gambaro; Tanguy Corre; Murielle Bochud; Peter Vollenweider; Idris Guessous; Marcus E Kleber; Graciela E Delgado; Stefan Pilz; Winfried März; Catriona L K Barnes; Peter K Joshi; James F Wilson; Martin H de Borst; Gerjan Navis; Pim van der Harst; Hiddo J L Heerspink; Georg Homuth; Karlhans Endlich; Matthias Nauck; Anna Köttgen; Cristian Pattaro; Pietro Manuel Ferraro
Journal:  Nephrol Dial Transplant       Date:  2018-12-01       Impact factor: 7.186

7.  Non-linear association of serum 25-hydroxyvitamin D with urinary albumin excretion rate in normoalbuminuric subjects.

Authors:  Yun Jung Oh; Rae Woong Park; Dukyong Yoon; Myounghee Kim; Seung Seok Han; Hye Ryoun Jang; Hyosang Kim; Nam Ju Heo; Su-Kil Park; Hajeong Lee; Kwon Wook Joo; Chun-Soo Lim; Yon Su Kim; Dong Ki Kim
Journal:  BMC Nephrol       Date:  2014-06-24       Impact factor: 2.388

8.  A double-blind, randomized, placebo-controlled trial of combined calcitriol and ergocalciferol versus ergocalciferol alone in chronic kidney disease with proteinuria.

Authors:  Paweena Susantitaphong; Siriwan Nakwan; Sadudee Peerapornratana; Khajohn Tiranathanagul; Pisut Katavetin; Nattachai Srisawat; Kearkiat Praditpornsilpa; Somchai Eiam-Ong
Journal:  BMC Nephrol       Date:  2017-01-14       Impact factor: 2.388

9.  Effect of Vitamin D Supplementation on Kidney Function in Adults with Prediabetes: A Secondary Analysis of a Randomized Trial.

Authors:  Sun H Kim; Irwin G Brodsky; Ranee Chatterjee; Sangeeta R Kashyap; William C Knowler; Emilia Liao; Jason Nelson; Richard Pratley; Neda Rasouli; Ellen M Vickery; Mark Sarnak; Anastassios G Pittas
Journal:  Clin J Am Soc Nephrol       Date:  2021-08       Impact factor: 10.614

10.  Evaluating hormonal mechanisms of vitamin D receptor agonist therapy in diabetic kidney disease: the VALIDATE-D study.

Authors:  Jenifer M Brown; Kristina Secinaro; Jonathan S Williams; Anand Vaidya
Journal:  BMC Endocr Disord       Date:  2013-08-23       Impact factor: 2.763

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.